2018
DOI: 10.2478/enr-2018-0026
|View full text |Cite
|
Sign up to set email alerts
|

Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review

Abstract: Polycystic Ovary Syndrome (PCOS) is characterized by hyperandrogenism, amenorrhea, and polycystic ovaries. This endocrinopathy is associated with many metabolic disorders such as dyslipidemia and insulin resistance, with increased risk of type 2 diabetes mellitus, metabolic syndrome, and cardiovascular complications. Inflammation is likely to play an important role in the promoting these metabolic imbalances, while prothrombotic and pro-oxidative mechanisms further contribute to the cardiovascular risk of thes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
26
1
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 36 publications
(30 citation statements)
references
References 129 publications
(151 reference statements)
1
26
1
2
Order By: Relevance
“…PCOS is the main hyperandrogenic endocrinopathy in women during their menacme. Its pathophysiology is complex, and it is endowed with several molecular routes with multiple hormonal components, inflammatory and homeostatic alterations that are characterized mainly by insulin resistance and hyperandrogenism [10]. Its relationship with lipid and glycidic metabolism disorders has been the target of many studies, and currently PCOS is considered a metabolic disease, with all its implications [4].…”
Section: Discussionmentioning
confidence: 99%
“…PCOS is the main hyperandrogenic endocrinopathy in women during their menacme. Its pathophysiology is complex, and it is endowed with several molecular routes with multiple hormonal components, inflammatory and homeostatic alterations that are characterized mainly by insulin resistance and hyperandrogenism [10]. Its relationship with lipid and glycidic metabolism disorders has been the target of many studies, and currently PCOS is considered a metabolic disease, with all its implications [4].…”
Section: Discussionmentioning
confidence: 99%
“…These women typically present hyperandrogenism, amenorrhea, and polycystic ovaries [223,224]. Patients with PCOS show obesity (visceral phenotype), lipid disorders, IR, compensatory hyperinsulinemia, and they have a higher risk of type 2 diabetes mellitus, metabolic syndrome, cardiovascular complications, reproductive disorders (best review by [225]). Regarding the IR, the hyperinsulinemia-associated increases pituitary luteinizing hormone (LH) secretion and ovary theca cells androgen production; contextually it suppresses the sex hormone-binding globulin (SHBG) production in the liver leading to an enhance of free androgens in the blood that in turn further worsens the insulin resistance [226].…”
Section: Chronic Diseases From Lifestyle To Pparsmentioning
confidence: 99%
“…1). In addition, higher levels of anti-Müllerian hormone (AMH) are a result of increased number of small antral follicles [1], impairing the follicle growth and the selection of a dominant follicle [8].…”
Section: Introductionmentioning
confidence: 99%